Paris, Île-de-France, France
Responsable développement clinique des études en oncologie en phase I et II.
Responsable développement clinique des études en phase I et II en oncologie
Overview of the clinical activities of EMEA countries for phase II and III studies in oncology. CRA and CTA overview, TMF and clinical database overview. Escalation point for clinical issues. Main contact point for Sponsor
Management of a clinical research center for a large study in viral hepatitis (HEPATHER): Coordination of clinical service and diagnostic facility, preparation of patient bio-banks, sample logistics Patient recruitment, clinical database, research projects, regulatory affairs
Project leader (preclinical development of an anti-inflammatory treatment), Immunotherapix; Paris — since 2009 Collaborative research project with a large pharmaceutical group: Development and validation of tests for the quantification of biomarkers,studies on pharmacokinetics Characterisation of an anti-inflammatory treatment with mouse models Isolation and production of the active principle: solubilisation, purification and lyophilisation
Research Cordinator, Quintiles: Levallois-Perret — 2009 Participation at a PhaseIII study : Investigator support (telephone, distance monitoring, electronic case report forms), presentations at investigator meetings in Switzerland and Germany Présentations orales au cours de réunions investigateurs en Suisse et en Allemagne